Search





Search





Markets
/
Stocks
/
cntx
/

Context Therapeutics Inc

CNTX

Add to Watchlist

0.599USD

-0.008-1.30%

Close 07-31 16:00（ET）Quotes delayed by 15 min

55.07MMarket Cap

LossP/E TTM

Context Therapeutics Inc

0.599

-0.008-1.30%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

CNTX Cash Flow Statement

You can access the annual and quarterly cash flow statements of Context Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-127.30%-11.43M

-82.26%-8.94M

-240.29%-6.58M

-73.89%-5.84M

-15.31%-5.03M

32.11%-4.91M

44.14%-1.93M

27.54%-3.36M

23.88%-4.36M

-83.91%-7.23M

-15.59%-3.46M

-65.09%-4.63M

-49.95%-5.73M

20.80%-3.93M

-6762.00%-2.99M

-34.93%-2.81M

-122.72%-3.82M

-2718.74%-4.96M

87.54%-43.63K

-547.56%-2.08M

-815.53%-1.72M

---176.03K

---350.20K

---321.04K

---187.35K

Net income from continuing operations

-89.65%-8.68M

-289.65%-13.03M

44.48%-9.69M

-291.55%-8.83M

-24.80%-4.58M

50.62%-3.34M

-197.21%-17.46M

55.01%-2.25M

41.86%-3.67M

-90.34%-6.77M

-52.42%-5.87M

-25.71%-5.01M

-83.47%-6.31M

-15.04%-3.56M

-167.14%-3.85M

20.75%-3.99M

-285.44%-3.44M

-293.99%-3.09M

-64.66%-1.44M

-167.26%-5.03M

-207.93%-892.05K

---784.75K

---876.24K

--7.48M

--826.48K

Operating gains losses

15.59%4.69K

38.55%4.07K

44.65%4.07K

58.29%4.07K

57.90%4.05K

14.25%2.93K

-9.00%2.81K

-19.60%2.57K

-19.57%2.57K

-19.60%2.57K

-3.26%3.09K

10.86%3.19K

--3.19K

--2.88K

----

Other non-cash items

20.78%31.42K

7910.63%2.03M

-99.81%27.46K

--26.73K

--26.01K

--25.32K

196210.86%14.77M

-100.00%0.00

-65.01%7.52K

-95.71%22.37K

57.44%22.07K

--21.79K

117.12%21.50K

-83.12%521.22K

--14.02K

--0.00

---125.58K

--3.09M

----

Change in working capital

-312.20%-3.19M

194.59%1.73M

407.08%2.76M

304.02%2.57M

17.16%-774.90K

-154.77%-1.82M

-74.67%544.25K

-1862.27%-1.26M

-444.11%-935.40K

-11.60%-715.90K

284.30%2.15M

-82.80%71.55K

144.50%271.83K

68.80%-641.51K

-58.95%559.00K

166.21%415.91K

32.30%-610.92K

-465.37%-2.06M

404.25%1.36M

-309.44%-628.15K

-586.07%-902.38K

--562.70K

--270.04K

--299.92K

--185.65K

-Change in prepaid expenses

-1961.29%-1.63M

89.17%-237.84K

1317.62%1.31M

75.21%-52.59K

-86.49%87.56K

-623.01%-2.20M

-108.42%-107.63K

53.35%-212.14K

170.55%647.89K

-294.95%-303.85K

236.90%1.28M

-1.16%-454.72K

-51.23%239.48K

109.73%155.86K

-31132.35%-933.45K

-3998.02%-449.51K

28224.46%491.05K

-38411.05%-1.60M

-52.13%3.01K

18.59%-10.97K

-123.79%-1.75K

--4.18K

--6.28K

---13.47K

--7.34K

-Change in other current assets

----

--0.00

-100.00%0.00

-15.60%24.00K

105.00%2.19K

127.34%6.56K

--6.56K

--28.44K

---43.75K

---24.00K

----

Cash from non-recurring investing activities

Cash from operating activities

-127.30%-11.43M

-82.26%-8.94M

-240.29%-6.58M

-73.89%-5.84M

-15.31%-5.03M

32.11%-4.91M

44.14%-1.93M

27.54%-3.36M

23.88%-4.36M

-83.91%-7.23M

-15.59%-3.46M

-65.09%-4.63M

-49.95%-5.73M

20.80%-3.93M

-6762.00%-2.99M

-34.93%-2.81M

-122.72%-3.82M

-2718.74%-4.96M

87.54%-43.63K

-547.56%-2.08M

-815.53%-1.72M

---176.03K

---350.20K

---321.04K

---187.35K

Investing cash flow

Net cash from continuing investing activities

9.75%37.26K

--0.00

-100.00%0.00

--0.00

--33.95K

--0.00

--7.32K

----

--0.00

-100.00%0.00

--0.00

--1.84K

--35.00K

----

Capital expenditures

9.75%37.26K

--0.00

-100.00%0.00

--0.00

--33.95K

--0.00

--7.32K

----

--0.00

-100.00%0.00

--0.00

--1.84K

--35.00K

----

Net cash flow from disposal of fixed assets

9.75%37.26K

--0.00

-100.00%0.00

--0.00

--33.95K

--0.00

--7.32K

----

--0.00

-100.00%0.00

--0.00

--1.84K

--35.00K

----

Net cash flow from other investing activities

--0.00

---2.00M

100.00%0.00

----

--0.00

---14.75M

----

--0.00

----

--0.00

---500.00K

----

--0.00

---250.00K

----

Cash from non-current investing activities

Net cash flow from investing activities

-9.75%-37.26K

---2.00M

100.00%0.00

--0.00

---33.95K

--0.00

---14.76M

----

--0.00

100.00%0.00

--0.00

---500.00K

99.27%-1.84K

---35.00K

--0.00

---250.00K

----

Financing cash flow

Cash flow from continuous financing activities

100.00%0.00

-100.00%0.00

100.00%0.00

-100.00%0.00

---15.27K

--14.54M

---44.63K

--94.80M

----

--0.00

100.00%0.00

-100.00%0.00

100.00%0.00

-100.00%0.00

-103.36%-102.07K

15393.75%54.23M

-281.54%-816.92K

501.23%1.95M

12038.10%3.03M

--350.00K

--450.00K

--324.05K

--25.00K

Net cash flow from debt Issuance/repayment

----

--0.00

-100.00%0.00

--0.00

--124.05K

--25.00K

Net cash flow from common stock issuance/repurchase

--0.00

-100.00%0.00

--0.00

----

--14.54M

----

--53.41M

----

Net cash flow from preferred stock issuance/repurchase

----

--0.00

-100.00%0.00

874.15%1.95M

--3.03M

--350.00K

--450.00K

--200.00K

--0.00

Net cash flow from other financing activities

100.00%0.00

--0.00

100.00%0.00

--0.00

---15.27K

--0.00

---44.63K

----

--0.00

100.00%0.00

-100.00%0.00

100.00%0.00

--0.00

---102.07K

--816.92K

---816.92K

----

Net cash from non-recurrent financing activities

Net cash from financing activities

100.00%0.00

-100.00%0.00

100.00%0.00

-100.00%0.00

---15.27K

--14.54M

---44.63K

--94.80M

----

--0.00

100.00%0.00

-100.00%0.00

100.00%0.00

-100.00%0.00

-103.36%-102.07K

15393.75%54.23M

-281.54%-816.92K

501.23%1.95M

12038.10%3.03M

--350.00K

--450.00K

--324.05K

--25.00K

Net cash flow

Beginning cash balance

-30.11%66.00M

-9.27%76.94M

-17.75%83.52M

785.62%89.35M

553.50%94.43M

291.21%84.80M

303.92%101.54M

-66.11%10.09M

-59.29%14.45M

-45.02%21.68M

-41.43%25.14M

-34.90%29.77M

-28.56%35.50M

9306.40%39.43M

3254.00%42.92M

2654.20%45.73M

14468.97%49.69M

150.90%419.15K

1802.42%1.28M

2484.06%1.66M

50.50%341.04K

--167.06K

--67.27K

--64.25K

--226.60K

Current period cash flow changes

-125.83%-11.47M

-213.65%-10.94M

60.69%-6.58M

-106.38%-5.84M

-16.44%-5.08M

233.22%9.63M

-383.55%-16.74M

2074.64%91.45M

23.88%-4.36M

-83.91%-7.23M

0.95%-3.46M

-64.98%-4.63M

-44.75%-5.73M

-107.98%-3.93M

-306.03%-3.49M

-637.51%-2.81M

-399.96%-3.96M

28218.11%49.27M

-962.32%-860.55K

-12723.88%-380.61K

912.61%1.32M

--173.97K

--99.80K

--3.02K

---162.35K

Ending cash balance

-38.97%54.53M

-30.11%66.00M

-9.27%76.94M

-17.75%83.52M

785.62%89.35M

553.50%94.43M

291.21%84.80M

303.92%101.54M

-66.11%10.09M

-59.29%14.45M

-45.02%21.68M

-41.43%25.14M

-34.90%29.77M

-28.56%35.50M

9306.40%39.43M

3254.00%42.92M

2654.20%45.73M

14468.97%49.69M

150.90%419.15K

1802.42%1.28M

2484.06%1.66M

--341.04K

--167.06K

--67.27K

--64.25K

Free cash flow

-126.51%-11.47M

-82.26%-8.94M

-239.00%-6.58M

---5.84M

---5.06M

32.11%-4.91M

43.93%-1.94M

----

-83.91%-7.23M

-15.59%-3.46M

-64.98%-4.63M

-48.59%-5.73M

20.80%-3.93M

-6762.00%-2.99M

-35.02%-2.81M

---3.86M

---4.96M

---43.63K

---2.08M

----

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Context Therapeutics Inc Generate?



Context Therapeutics Inc generated -26.39M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Context Therapeutics Inc's Operating Cash Flow Change Year Over Year?



Context Therapeutics Inc's operating cash flow increased by -81.26% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Context Therapeutics Inc Spend on Capital Expenditures?



Context Therapeutics Inc spent 33.95K on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Context Therapeutics Inc's Financing Cash Flow Changed?



Context Therapeutics Inc used -15.27K in financing activities in the latest quarter.

What is free cash flow and why does it matter for CNTX?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Context Therapeutics Inc’s free cash flow in the latest quarter?



Free cash flow was -26.42M reflecting a -81.40% change from the previous year.